Cite
MLA Citation
Michael B Arnold et al.. “Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis.” Rheumatology, vol. 57, 2018, pp. 152–157. http://access.bl.uk/ark:/81055/vdc_100095517882.0x00000f